Compare GSK plc (GSK) vs LYFT Inc (LYFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs LYFT Inc — how do they compare? GSK plc trades at $51.15 (market cap $102.60B), while LYFT Inc trades at $16.59 (market cap $6.64B). The key difference: GSK plc is far larger — about 15.5× LYFT Inc's market cap, and GSK plc pays a 3.57% dividend while LYFT Inc pays none. Which is the better fit depends on your goals.
| GSK | LYFT | |
|---|---|---|
Market Cap | $102.60B | $6.64B |
Sector | Health | Industrials |
52-Week High | $61.18 | $24.57 |
52-Week Low | $38.22 | $12.65 |
Enterprise Value | $123.04B | $6.11B |
Dividend Yield | 3.57% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
Lyft trades at $16.42, down 4.87% today, with a bullish technical outlook from moving averages but bearish oscillators. The company reported Q2 2026 revenue growth of 16.1% to a record $5.5 billion in gross bookings, though EPS missed estimates. Strong cash flow generation and expanding global rider base support fundamentals, while valuation ratios like P/E of 2.55 appear attractive relative to historical norms.
Lyft's outlook is mixed: robust revenue growth and cash flow provide upside potential, but earnings misses and competitive pressures from Uber pose risks. The stock offers value with a consensus price target of $19.17, representing 17% upside, though investors face headwinds from rising expenses and market share battles in the ride-hailing sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About LYFT Inc
Lyft is the second-largest ride-sharing service provider in the U.S., connecting riders and drivers over the Lyft app. Lyft recently entered the Canadian market in an effort to expand its market outside the U.S. Incorporated in 2013, Lyft offers a variety of rides via private vehicles, including traditional private rides, shared rides, and luxury ones. Besides ride-share, Lyft also has entered the bike- and scooter-share market to bring multimodal transportation options to users.
Read more on LYFT →
